MRES (Institute of Biomedical Research) Other Stockholders Equity: $0.00 Mil (As of Dec. 2010)


What is Institute of Biomedical Research Other Stockholders Equity?

Institute of Biomedical Research MRES Other Stockholders Equity is $0.00 Mil as of Dec. 2010.

Institute of Biomedical Research's Other Stockholders Equity for the quarter that ended in Dec. 2010 was $0.00 Mil.

Institute of Biomedical Research's quarterly Other Stockholders Equity declined from Jun. 2010 ($0.00 Mil) to Sep. 2010 ($0.00 Mil) and declined from Sep. 2010 ($0.00 Mil) to Dec. 2010 ($0.00 Mil).

Institute of Biomedical Research's annual Other Stockholders Equity declined from Mar. 2008 ($0.00 Mil) to Mar. 2009 ($0.00 Mil) and declined from Mar. 2009 ($0.00 Mil) to Mar. 2010 ($-0.00 Mil).

Institute of Biomedical Research Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Other Stockholders Equity Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 -0.00 0.00 0.00 -0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 0.00

Institute of Biomedical Research Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Institute of Biomedical Research (MRES) has a Other Stockholders Equity of $0.00 Mil as of Dec. 2010. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Other Stockholders Equity too high?
Institute of Biomedical Research's current Other Stockholders Equity is $0.00 Mil.
How does Institute of Biomedical Research's Other Stockholders Equity compare to HSTC and NTRR?
Institute of Biomedical Research's Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Other Stockholders Equity is $0.00 Mil as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.